India Endoscopy Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

India Endoscopy Devices Market Trends and Insights

Rising Prevalence of Gastrointestinal Diseases

India carries the world’s highest burden of enteric infections, and inflammatory bowel disease cases are projected to jump 69% from 270,000 in 2019 to 457,000 by 2050, expanding screening demand.^{[1]World Health Organization, “Inflammatory Bowel Disease in South Asia,” who.int} Ayushman Bharat issued 420 million health cards to 33,000 hospitals by 2025, unlocking latent rural demand for upper and lower GI scopes. Tier-2 facilities now add day-care endoscopy suites that prefer flexible scopes over robotic platforms, aligning with cost ceilings. National cancer-control guidelines that mandate protocol-driven surveillance are also lengthening replacement cycles as high-volume sites seek durable, fast-reprocessing models.

Government Healthcare Expenditure & Insurance Expansion

Public health outlay rose from 0.9% of GDP in 2004 to 2.1% in 2023, and the FY25 Union Budget earmarked INR 9,406 crore (USD 1.13 billion) for Ayushman Bharat.^{[2]Federation of Indian Chambers of Commerce & Industry, “Ayushman Bharat Performance Review,” ficci-india.org} PM-JAY’s package-rate reimbursements for colonoscopy, ERCP, and polypectomy assure baseline volumes that de-risk hospital investment. Tamil Nadu’s state insurance, integrated with PM-JAY, covers up to INR 500,000 per family member, stimulating private-sector endoscopy growth. North India, where bed density trails the south, is on track for 12-14% healthcare-delivery CAGR to FY28, translating into brisk device procurement. However, lower package prices pressure facilities to prefer reusable scopes unless outbreaks raise single-use uptake.

HD/4K, AI & Single-Use/Capsule Endoscopy Innovations

Fujifilm’s ELUXEO 8000 system, launched in April 2025, ships with amber-red color imaging and extended dynamic-range processing to improve lesion visibility. Stryker’s 1788 platform debuted in September 2024 with a 62.5 times wider color gamut and fluorescence modes for perfusion mapping. Fujifilm’s Gastro AI Academy pilots cut polyp-miss rates 45% in 2024 screenings, accelerating 4K upgrades in tertiary centers. Single-use bronchoscopes from Ambu and Boston Scientific entice pulmonology units worried about reprocessing contamination; capsule endoscopy pilots support remote GI screening. The India-EU FTA’s tariff removal lowers the prices of imported devices by 15-20%, shortening payback periods for high-spec towers.

Expansion of Private Hospitals & ASCs

Hospital chains are investing INR 30,000-40,000 crore to add 34,000 beds by FY29, with 40% in Tier-2/3 cities, fueling demand for mid-range, flexible scopes priced at INR 1.7-2.6 million per camera stack. North India’s bed density of 16 per 10,000 is the lowest nationally, prompting a projected 12-14% CAGR in healthcare delivery that underpins volume growth. Stand-alone endoscopy-only centers in Kanpur, Patna, and Ludhiana leverage PM-JAY’s fixed packages to achieve faster equipment payback. Such clinics value bundled service contracts, consumables, and vendor-led training, tipping procurement toward suppliers that minimize the total cost of ownership.

High Capital Cost of Advanced Endoscopy Systems

AI-ready 4K towers cost INR 15-25 million (USD 180,000-300,000). Robotic platforms such as Intuitive Surgical’s da Vinci 5, deployed in 76 Indian installations by Q3 2024, demand multi-million-dollar budgets that most public facilities lack. State hospitals wrestle with staggered funding and delayed receivables, curbing big-ticket purchases despite tariff relief. Private hospitals mitigate risk through leasing and outcome-based service contracts, but these shift margin pressure onto vendors. Consequently, many buyers continue to favor durable, lower-spec reusable scopes over premium disposables even after the FTA price cut.

Shortage of Trained Endoscopists & Reprocessing Staff

Only 1,500-2,000 gastroenterologists serve 1.4 billion Indians, one per 700,000-900,000 people, versus one per 50,000 in developed markets. Training programs cluster in metros; rural and Tier-3 cities often have none. AIIMS reported 87,209 surgical cases in 2021-22 and runs simulation labs, but the national fellowship capacity lags demand. Technician shortages slow reprocessing, prompting some pulmonology units to adopt single-use bronchoscopes despite higher per-case costs. Fujifilm’s second Mumbai service center, opened in July 2024, pairs repair with technician upskilling to reduce downtime. Without medical-education reform, procedural capacity will remain the primary bottleneck on India endoscopy devices market growth.

Segment Analysis

By Device Type: Visualization Equipment Outpaces Legacy Endoscope Growth

Visualization equipment revenue is projected to rise at an 8.55% CAGR from 2026-2031, surpassing endoscopes, which still held 61.62% of India endoscopy devices market share in 2025. The launch of Stryker’s 1788 platform lets hospitals install 4K imaging and fluorescence without replacing entire scope fleets. Rigid endoscopes dominate ENT and orthopedic procedures, while flexible scopes remain foundational for GI and pulmonology. Capsule endoscopy serves remote-screening pilots, and robotic scopes remain a niche 76-unit installed base. Domestically, PLI-enabled assemblers can now import zero-duty optics post-FTA, helping them supply mid-range 4K towers to Tier-2 buyers.

Hospitals view visualization towers as a shared asset across specialties, generating quicker ROI than single-discipline robots. AI-enabled processors that overlay polyp-detection prompts raise adenoma-detection rates and drive upgrades. Advanced operative tools, such as Fujifilm’s 360° Tracmotion ESD device, expand the therapeutic scope of demand. Net effect: visualization-first upgrades lengthen the life of reusable scopes, widening the installed base and unlocking recurring accessories revenue for suppliers.

Note: Segment shares of all individual segments available upon report purchase

By Application: Gynecology Endoscopy Surges on Fertility and Day-Care Demand

Gastrointestinal procedures accounted for 44.13% of India's endoscopy devices market in 2025. Yet gynecology will post the fastest growth, with an 8.97% CAGR through 2031, as fertility clinics favor hysteroscopy and laparoscopy for PCOS and endometriosis. Laparoscopy remains the No. 2 application across bariatrics and oncology. Pulmonology growth is tied to the burden of COPD and the adoption of single-use bronchoscopes. ENT volumes pivot around functional endoscopic sinus surgery; urology benefits from aging demographics and rising prostate cancer diagnoses. Cardiology uses transesophageal scopes for structural heart interventions, but remains a niche.

Fertility-center expansion in Tier-2 hubs creates day-care throughput, rewarding mid-tier 4K systems with rapid instrument turnarounds. Package-rate reimbursements under PM-JAY also encourage gynecology units to adopt reusable hysteroscopes. Meanwhile, GI demand continues to surge thanks to aging, rising IBD, and new screening protocols. The dual-engine effect ensures diversified opportunities within the Indian endoscopy devices market.

By Usability: Single-Use Devices Gain Ground on Infection-Control Mandates

Reusable scopes accounted for 83.78% of revenue in 2025; however, single-use devices will grow at a 10.01% CAGR following multiple biofilm-related alerts. Automated reprocessors boost per-case costs by INR 500-1,000, eroding reusable economics in high-volume pulmonology. Hospitals with weak sterile-processing infrastructure choose Ambu or Boston Scientific disposables. Yet high-throughput tertiary centers still favor reusables, relying on Fujifilm’s expanded Mumbai repair hub to maintain high uptime.

Tariff removal narrows price gaps, but widespread adoption of disposables hinges on payors' willingness to fund higher consumable outlays. Domestic PLI players concentrate on reusable flexible scopes for public-sector bids, constrained by imported optics. The resulting usability mix should stabilize with disposables penetrating infection-prone specialties and reusables dominating multiprocedure environments.

Note: Segment shares of all individual segments available upon report purchase

By End User: Specialty Clinics Capitalize on Package-Rate Optimization

Hospitals accounted for 75.38% of 2025 revenue, yet specialty clinics will grow fastest at a 12.01% CAGR through 2031. Clinics in Lucknow, Patna, and Ludhiana offer procedure-only packages, slashing overhead and improving asset turns. They deploy mid-range towers costing INR 1.7-2.6 million, often on vendor financing. Diagnostic centers add capsule endoscopy to reach rural populations via telemedicine.

Hospital procurement still dominates high-acuity therapeutic gear such as ERCP duodenoscopes and robotic systems. Private chains earmark INR 2.5-3 million per new bed for devices, supporting both premium and mid-tier purchases. Government hospitals, despite having 850,000 beds, struggle with fragmented funding but remain a vast, addressable market for rugged, reusable scopes. The Indian endoscopy devices market thus bifurcates between high-spec metro hospitals and value-focused clinics, each with different vendor-selection criteria.

Geography Analysis

North India will post the fastest regional growth at 12-14% CAGR to FY28 as private investors close the region’s 10-bed density gap versus the south. INR 30,000-40,000 crore in fresh capital targets 34,000 new beds, reserving INR 2.5-3 million per bed for equipment, including endoscopes. Tier-2 clusters such as Kanpur and Meerut lean toward bundled mid-range scopes suited to PM-JAY tariffs. Flexible gastroscopes with durable insertion tubes and low reprocessing costs appeal most.

Maharashtra, Karnataka, Tamil Nadu, and Delhi-NCR remain revenue leaders owing to dense tertiary centers and 690,000 foreign patients treated in 2023. Tamil Nadu’s state scheme empanelled 1,137 hospitals, guaranteeing volumes that cross-subsidize premium 4K towers. Metro hospitals installed Fujifilm’s ELUXEO 8000 in early 2025 to retain tourism clientele seeking AI-assisted precision.

The India-EU FTA’s tariff cuts benefit metro buyers able to absorb higher-spec imports, whereas Tier-2/3 buyers still prefer PLI-backed domestic options. Medtech parks in Uttar Pradesh and Tamil Nadu aim to shorten supply chains for these regions, but optics' reliance on Japan and Germany persists. Overall, the India endoscopy devices market displays a two-speed geography: value-driven north and technology-driven metros.